VNTC Secures Series B Funding... Accelerates Product Advancement and Global Expansion

[Asia Economy Reporter Hyungsoo Park] VNTC, which developed a new-concept scoliosis brace, announced on the 10th that it has secured Series B investment from Crystal Bioscience.

Crystal Genomics, a technology-specialized first KOSDAQ-listed new drug development company, established Crystal Bioscience with 100% capital investment. It discovers and invests in startups with excellent technological capabilities through a systematic and differentiated screening process. It is a new technology business finance company (Venture Capital) aiming to build strategic partnerships such as licensing and open innovation. It was selected as a Korean mother fund operator in the first half of this year. It focuses investments not only on innovative new drugs but also on smart healthcare, bioinformatics, and other fields. The Series B investment funds were also raised from this fund.

VNTC has laid the groundwork to grow in the smart healthcare sector. With the invested funds, VNTC plans to enhance its products and expand its distribution network through global dealerships.

VNTC is developing the garment-type scoliosis brace ‘Spynamic for AIS’ aimed at improving Quality of Life (QOL). In addition, it offers diversified products and services such as the ‘Fitmove’ back brace and ‘Fitmove’ knee brace, which enhance mobility.

‘Spynamic for AIS’ is the world’s first garment-type scoliosis brace developed through in-house research and development. It corrects spinal curvature by applying pressure to the curvature points and prevents the condition from worsening.

It implements essential correction principles such as deflexion, derotation, and elongation, equivalent to rigid braces, through various bands, pads, and pressure control devices. The dial device allows adjustment of pressure intensity according to the patient’s condition improvement. It can also be customized based on adolescent growth status. From a design perspective, it reduces visual burden and provides comfortable wear, helping patients easily comply with the recommended 18 hours of daily wear time.

While conventional scoliosis braces take two weeks to manufacture, ‘Spynamic for AIS’ is provided on the same day based on X-ray data and measurements tailored to the patient’s condition.

In June, VNTC signed a domestic exclusive distribution contract for the hybrid scoliosis brace ‘Spynamic for AIS’ with Dong-A ST. It currently has 23 dealerships and is expanding its nationwide distribution network by signing additional contracts with over 30 dealerships.

This content was produced with the assistance of AI translation services.